MLYS
Mineralys TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MLYS vs peer average
49/100
MLYS vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 3 · D 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IDYA is the first available peer comparator.
IDEAYA is a similarly sized development-stage biotech, useful mainly as a valuation/risk appetite comp rather than an indication peer; both trade on pipeline execution and financing/runway credibility.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MLYS
Mineralys Therapeutics
IDYA
IDEAYA Biosciences
Grade
C
A
Momentum
37
85
Value
41
41
Sentiment
79
67
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs IDYA
MLYS / IDYA
Grade Position
In line
MLYS vs. peer average (C vs. C)
49/100
Momentum
37
IDYAValue
41
MLYSSentiment
79
MLYSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MLYS
IDYA is the first peer returned for this comparison set.